ProNAi Therapeutics (DNAI) Posts Wider Q2 Loss
Tweet
Share
E-mailGet Alerts DNAI Hot Sheet
Join SI Premium – FREE
ProNAi Therapeutics (NASDAQ: DNAI) reported Q2 EPS of ($104.10), versus ($55.04) reported last year.
For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
